• Bernatowska, E., Madalinski, K., Janowicz, W., Weremowicz, R., Gutkowski, P., Wolf, H. & Eibl, M. (1987) Results of a prospective, controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment. Clin. Immunol. Immunopathol. 43, 153.
  • Björkander, J., Bake, B., Oxelius, V.-A. & Hanson, L. (1985) Impaired lung function in IgA deficiency and low levels of lgG2 or IgG3. N. Engl. J. Med. 313, 720.
  • Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia (1988) Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia: a randomized, controlled clinical trial. N. Engl. J. Med. 319, 902.
  • Eibl, M. & Wedgwood, R. (1989) Intravenous immunoglobulin: a review. Immunodef. Rev. 1 (Suppl.), 1.
  • Eibl, M., Cairns, L. & Rosen, F. (1984) Safety and efficacy of a monomeric, functionally intact intravenous IgG preparation in patients with primary immunodeficiency syndromes. Clin. Immunol. Immunopathol. 31, 151.
  • Gelter-Bernstein, C, Zur, S., Kahane, P., Weisglass, L. & Lahav, M. (1976) Serum immunoglobulins in children with asthma associated with severe respiratory tract infections. Ann. Allergy, 37, 126.
  • Goldblatt, D., Turner, M.W. & Levinsky, R.J. (1991) Delayed maturation of antigen-specific lgG3: another variant of pediatric immunodeficiency Progress in Immune Deficiency III, p. 109. Royal Society of Medicine Services Ltd., London .
  • Hanson, L., Björkander, J. & Wadsworth, C. (1983) Intramuscular and intravenous administration of immunoglobulin to patients with hypogammaglobulinemia. In Primary Immunodeficiency Diseases; Birth Defects: Original Article Series 19 (ed. by R.Wedgwood, F.Rosen & N.Paul) p. 205. Alan R. Liss, New York .
  • Hazer, B., Giclas, P. & Gelfand, E. (1989) Immunomodulatory effects of intravenous immunoglobulin in severe steroid-dependent asthma. Clin. Immunol. Immunopathol. 53, 5156.
  • Iuis/who notice (1983) Appropriate uses of human immunoglobulin in clinical practice. Clin. exp. Immunol. 52, 417.
  • Leibl, H., Liszka, K., Bernatowska, E., Mannhalter, J. & Eibl, M. (1991) Serum IgG subclass concentration in patients with undue susceptibility to infections. EOS. J. Immunol. Immunopharmacol. XI, 40.
  • Newburger, J., Takahashi, M., Burns, J., Beiser, A., Chung, K., Duffy, E., Glode, M., Mason, W., Reddy, V., Sanders, S., Shulman, S., Wiggins, J., Hicks, R., Fulton, D., Lewis, A., Leung, D., Colton, T., Rosen, F. & Melish, M. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315, 341.
  • Oxelius, V.-A. (1979) Quantitative and qualitative investigations of serum IgG subclasses in immunodeficiency diseases. Clin. exp. Immunol. 36, 112.
  • Page, R., Friday, G., Stillwagon, P., Skoner, D., Calguiri, L. & Fireman, P. (1988) Asthma and selective immunoglobulin subclass deficiency: improvement of asthma after immunoglobulin replacement therapy. J. Pediatr. 112, 127.
  • Robertson, D.M., Bjorkander, J., Henrichsen, J., Söoderström, T. & Hanson, L.A. (1989) Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency. Clin. exp. Immunol. 75, 201.
  • Roifman, C., Lederman, H., Lavi, S., Stein, L., Levison, H. & Gelfand, E. (1985) Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am. J. Med. 79, 171.
  • Roifman, C., Levison, H. & Gelfand, E. (1987) High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet, i, 1075.
  • Scientific Group on Immunodeficiency (1989) Primary immunodeficiency diseases—a report of a WHO-sponsored meeting. Immunodef. Rev. 1, 173.